Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: A promise for the near future.

Dolinger, David L; Colman, Rebecca E; Engelthaler, David M; Rodwell, Timothy C.

Afiliação

Dolinger DL; Foundation for Innovative New Diagnostics, Geneva, Switzerland. Electronic address: david.dolinger@finddx.org.
Colman RE; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Engelthaler DM; Pathogen Genomics, Translational Genomics Research Institute, Flagstaff, AZ, USA.
Rodwell TC; Foundation for Innovative New Diagnostics, Geneva, Switzerland; Division of Pulmonary, Critical Care, and Sleep Medicine, University of San Diego, San Diego, CA, USA.

Int J Mycobacteriol ; 5 Suppl 1: S27-S28, 2016 Dec.

Article em En | MEDLINE | ID: mdl-28043592